Senores Pharmaceuticals Limited, a global research driven pharmaceutical company engaged in developing and manufacturing specialty, niche and complex products for Regulated and Emerging Markets, announced its unaudited financial results for the quarter ended June 30, 2026, reporting strong financial and operational performance across key business segments. The company delivered broad-based
Oriflame, the Swedish holistic beauty and wellbeing brand, today announced that it has entered into an agreement for the transfer of its manufacturing operations in India to Pure and Cure Healthcare Private Limited, a wholly owned subsidiary of Akums Drugs and Pharmaceuticals Limited, one of India's
Star Bio Pharma Global Pvt. Ltd., a rapidly growing pharmaceutical and nutraceutical ingredients manufacturer, has further strengthened its position in Indias specialty ingredients sector by emerging as the countrys leading exporter of high purity Vitamin K2 (2000 PPM). The company has also established itself as Bengalurus only manufacturer and
Researchers have developed 3D-printed contact lenses that have shown encouraging results in early laboratory studies, marking a significant step toward the future of personalized vision care. While the technology is still in the experimental stage, scientists believe it could pave the way for faster, more
Defence Minister Rajnath Singh has reaffirmed India's commitment to becoming a global leader in healthcare innovation by promoting indigenous research, medical technology and affordable healthcare solutions. Addressing a convocation ceremony in Lucknow, he said the country's growing capabilities in gene therapy, nuclear medicine, medical devices
Global eye care company Alcon is strengthening its investment strategy in India, citing the country's rapidly growing demand for vision care, increasing prevalence of myopia among younger populations and expanding need for advanced cataract treatment. The company is also evaluating future manufacturing opportunities in India
The implementation of the India United Kingdom Comprehensive Economic and Trade Agreement (CETA) marks a significant milestone in bilateral economic relations, creating new opportunities for India's healthcare, pharmaceutical and medical technology (MedTech) sectors. With 97.1% of tariff lines receiving zero-duty market access, the agreement is
India's medical technology (MedTech) market could expand to $35 billion by 2030, driven by rising healthcare demand, increasing exports and growing investor confidence, according to a new report by Bain & Company. The report positions India as one of the fastest growing MedTech markets in
The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945, introducing stricter regulatory controls on medicinal formulations containing high concentrations of ethyl alcohol. Under the revised rules, formulations containing more than 12% v/v ethyl alcohol in quantities exceeding 30 mL will now
Telangana has reaffirmed its ambition to emerge as a global hub for life sciences, biotechnology and pharmaceutical innovation, with IT and Industries Minister Duddilla Sridhar Babu outlining the state's long term vision while inaugurating India's first integrated oncology manufacturing facility developed by Ciro Pharma. Established with
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
